Crossmark

Nano-ellagic acid: inhibitory actions on aldose reductase and α-glucosidase in secondary complications of diabetes, strengthened by in silico docking studies

Crossref DOI link: https://doi.org/10.1007/s13205-020-02411-1

Published Online: 2020-09-17

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marella, Saritha https://orcid.org/0000-0001-6325-6394
Hema, Kanipakam

Shameer, Syed

Prasad, T. N. V. K. V.
Funding

Funding for this research was provided by:

Science and Engineering Research Board (PDF/2015/000534)
License Information

Text and Data Mining valid from 2020-09-17

Version of Record valid from 2020-09-17
More Information

Article History

Received: 4 February 2020

Accepted: 24 August 2020

First Online: 17 September 2020

Compliance with ethical standards

:

: The authors declare no competing financial interest.

Document is current

Any future updates will be listed below